Image Trademark with Serial Number 79085755
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79085755
Registration Number
3972716
Word Mark
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2018-01-12
Filing Date
2010-06-26
Registration Number
3972716
Registration Date
2011-06-07
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
050325, 260121 - Other leaves. Circles that are totally or partially shaded.
Published for Opposition Date
2011-03-22
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
ROACH, APRIL K
Statements
Indication of Colors claimed
The color(s) blue and green is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a green leaf inside a solid blue circle.
Goods and Services
Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flashes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system, pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; medicated sanitary preparations for the treatment, cleaning and protection of the skin; dietary supplements in the form of tablets, drops, capsules, extract preparations, balms or in liquid form, containing plant extracts; dietetic substances adapted for medical use, namely, dietetic foods, dietetic beverages, dietetic sugar, dietetic food supplements; medical and surgical plasters; plant extracts for pharmaceutical purposes and plant extracts used as dietetic substances adapted for medical use; nutritional additives for medical purposes, namely, dietary and nutritional supplements for human consumption; medicinal oils; vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; medicinal herbs; materials for dressings, namely, gauze and bandages; all purpose disinfectants
Goods and Services
Educational services, namely, providing classes and workshops in the field of health, health consciousness and health queries to medical practitioners, health specialists and/or patients, providing of training in particular providing information about education in the field of health, health consciousness and health queries for medical practitioners, health specialists and patients, also via the Internet
Goods and Services
Medical services; hygienic and beauty care for human beings; medical consultancy, consultancy in the fields of pharmaceutical advice and health, also via the Internet
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-01-12
Primary Code
005
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-01-12
Primary Code
041
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-01-12
Primary Code
044
Correspondences
Name
Norman H. Zivin
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1046788
International Registration Date
2010-06-26
International Publication Date
2010-09-09
International Renewal Date
2030-06-26
Auto Protection Date
2012-03-02
International Status
001 - Request for extension of protection established
International Status Date
2010-09-02
Priority Claimed In
True
Priority Claimed Date
2010-03-16
First Refusal In
True
Trademark Events
Event Date | Event Description |
2010-09-02 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2010-09-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2010-09-07 | APPLICATION FILING RECEIPT MAILED |
2010-10-04 | ASSIGNED TO EXAMINER |
2010-10-04 | NON-FINAL ACTION WRITTEN |
2010-10-05 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2010-10-05 | REFUSAL PROCESSED BY MPU |
2010-10-05 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2010-11-01 | REFUSAL PROCESSED BY IB |
2010-11-19 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
2011-01-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2011-01-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2011-01-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2011-01-18 | EXAMINERS AMENDMENT -WRITTEN |
2011-01-18 | EXAMINERS AMENDMENT E-MAILED |
2011-01-18 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2011-01-18 | EXAMINER'S AMENDMENT ENTERED |
2011-01-18 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2011-02-11 | ASSIGNED TO LIE |
2011-02-17 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2011-03-03 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2011-03-03 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2011-03-22 | PUBLISHED FOR OPPOSITION |
2011-03-22 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2011-06-07 | REGISTERED-PRINCIPAL REGISTER |
2011-09-07 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2011-11-01 | FINAL DISPOSITION PROCESSED |
2011-11-01 | FINAL DISPOSITION NOTICE SENT TO IB |
2012-04-22 | NEW REPRESENTATIVE AT IB RECEIVED |
2012-06-06 | NEW REPRESENTATIVE AT IB RECEIVED |
2013-02-26 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2014-06-12 | NEW REPRESENTATIVE AT IB RECEIVED |
2018-01-12 | CANCELLED SECTION 71 |
2018-09-12 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
2018-09-17 | GENERIC MADRID TRANSACTION CREATED |
2018-09-17 | GENERIC MADRID TRANSACTION SENT TO IB |
2018-09-28 | REFUSAL PROCESSED BY IB |
2018-10-19 | TOTAL INVALIDATION PROCESSED BY THE IB |
2018-12-04 | NEW REPRESENTATIVE AT IB RECEIVED |
2019-12-06 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2020-07-17 | INTERNATIONAL REGISTRATION RENEWED |